Advertisement

Related Videos

The Interventional Pharmacoeconomic Toolbox Panel Discussion

Varsha Gandhi, PhD, on Ibrutinib

Russell Szmulewitz, MD, on Alternative Dosing of Abiraterone in Prostate Cancer: Pharmacoeconomic Proof of Concept

Peter Clark, MA, MD, FRCP: A Payer Perspective

Clinical Trial Design: Statistical Options/Challenges Panel Discussion

Advertisement

Advertisement




Oct
14
Today In Oncology
Creatine
Incidence of Invasive Lobular Carcinoma Rising Faster Than Other Breast Cancers
Gaps Persist in Follow-Up Care Among Young Survivors of Breast Cancer
Ziftomenib in Relapsed or Refractory NPM1-Mutant AML
Advanced Biliary Tract Cancer Adding a Polymeric Micellar Paclitaxel to Gemcitabine Plus Cisplatin
View More 
Advertisement
© 2025 HSP News Service, L.L.C.
Conexiant Oncology Logo